Junhun Cho

机构：Samsung Medical Center, Sungkyunkwan University · ORCID：0000-0002-6089-9340

发表论文 149 篇 · 总被引 2326 次 · h-index 27

代表论文

• Efficacy of combined CD38 and PD-1 inhibition with isatuximab and cemiplimab for relapsed/refractory NK/T-cell lymphoma (2025 · Blood · 被引 9)
• Clinical outcomes of tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma: insights from a single-center study (2025 · International Journal of Hematology · 被引 4)
• Microbiome and metabolite biomarkers of CAR T-cell therapy outcomes in relapsed/refractory diffuse large B-cell lymphoma (2025 · Blood Advances · 被引 3)
• Long-term outcomes of 40 Gy CCRT with weekly cisplatin and systemic chemotherapy in limited-stage ENKTL (2026 · Blood Advances · 被引 2)
• Surgery Alone without Adjuvant Radiation Therapy for High- or Intermediate-Grade Salivary Gland Cancer (2025 · ORL · 被引 1)
• Real-world data analysis of survival outcomes of patients with primary mediastinal large B-cell lymphoma treated with immunochemotherapy: the role of consolidative radiation therapy (2025 · Blood Research · 被引 1)